Cost-utility analysis of pharmacogenomics-guided tacrolimus treatment in Austrian kidney transplant recipients participating in the U-PGx PREPARE study
The Pharmacogenomics Journal
by Vasileios Fragoulakis, Margarita-Ioanna Koufaki, Candace Joefield-Roka, Gere Sunder-Plassmann, Christina Mitropoulou
1M ago
The Pharmacogenomics Journal, Published online: 18 March 2024; doi:10.1038/s41397-024-00330-5 Cost-utility analysis of pharmacogenomics-guided tacrolimus treatment in Austrian kidney transplant recipients participating in the U-PGx PREPARE study ..read more
Visit website
A review of real-world evidence on preemptive pharmacogenomic testing for preventing adverse drug reactions: a reality for future health care
The Pharmacogenomics Journal
by Santenna Chenchula, Shubham Atal, Chakradhara Rao S Uppugunduri
1M ago
The Pharmacogenomics Journal, Published online: 15 March 2024; doi:10.1038/s41397-024-00326-1 A review of real-world evidence on preemptive pharmacogenomic testing for preventing adverse drug reactions: a reality for future health care ..read more
Visit website
Network pharmacology prediction, molecular docking and in vitro experiment explored the potential mechanism of Gaoyuan’an capsule in improving hypoxia tolerance
The Pharmacogenomics Journal
by Tianbo Jin, Xiaoli Liu, Yuhe Wang, Yijin Qi, Xuemei Li, Li Wang, Xue He
1M ago
The Pharmacogenomics Journal, Published online: 14 March 2024; doi:10.1038/s41397-024-00327-0 Network pharmacology prediction, molecular docking and in vitro experiment explored the potential mechanism of Gaoyuan’an capsule in improving hypoxia tolerance ..read more
Visit website
Pharmacogenetic and clinical risk factors for bevacizumab-related gastrointestinal hemorrhage in prostate cancer patients treated on CALGB 90401 (Alliance)
The Pharmacogenomics Journal
by Jai N. Patel, Chen Jiang, Kouros Owzar, Daniel L. Hertz, Janey Wang, Flora A. Mulkey, William K. Kelly, Susan Halabi, Yoichi Furukawa, Cameron Lassiter, Susan G. Dorsey, Paula N. Friedman, Eric J. Small, Michael A. Carducci, Michael J. Kelley, Yusuke Nakamura, Michiaki Kubo, Mark J. Ratain, Michael J. Morris, Howard L. McLeod
1M ago
The Pharmacogenomics Journal, Published online: 04 March 2024; doi:10.1038/s41397-024-00328-z Pharmacogenetic and clinical risk factors for bevacizumab-related gastrointestinal hemorrhage in prostate cancer patients treated on CALGB 90401 (Alliance ..read more
Visit website
Composite CYP3A (CYP3A4 and CYP3A5) phenotypes and influence on tacrolimus dose adjusted concentrations in adult heart transplant recipients
The Pharmacogenomics Journal
by Michelle Liu, Savine Hernandez, Christina L. Aquilante, Kimberly M. Deininger, Joann Lindenfeld, Kelly H. Schlendorf, Sara L. Van Driest
2M ago
The Pharmacogenomics Journal, Published online: 15 February 2024; doi:10.1038/s41397-024-00325-2 Composite CYP3A (CYP3A4 and CYP3A5) phenotypes and influence on tacrolimus dose adjusted concentrations in adult heart transplant recipients ..read more
Visit website
The pharmacogenetics of tacrolimus in renal transplant patients: association with tremors, new-onset diabetes and other clinical events
The Pharmacogenomics Journal
by Amani Abderahmene, Yassine khalij, Amira Moussa, Meriam Ammar, Amel Ellouz, Dorra Amor, Houwaida Abbes, Mohamed Rayen Ganouni, Wissal Sahtout, Saoussen Chouchene, Asma omezzine, Dorsaf zellama, Ali Bouslama
3M ago
The Pharmacogenomics Journal, Published online: 22 January 2024; doi:10.1038/s41397-024-00323-4 The pharmacogenetics of tacrolimus in renal transplant patients: association with tremors, new-onset diabetes and other clinical events ..read more
Visit website
Pharmacogenomic biomarker information on drug labels of the Spanish Agency of Medicines and Sanitary products: evaluation and comparison with other regulatory agencies
The Pharmacogenomics Journal
by María Estévez-Paredes, M. Carmen Mata-Martín, Fernando de Andrés, Adrián LLerena
3M ago
The Pharmacogenomics Journal, Published online: 17 January 2024; doi:10.1038/s41397-023-00321-y Pharmacogenomic biomarker information on drug labels of the Spanish Agency of Medicines and Sanitary products: evaluation and comparison with other regulatory agencies ..read more
Visit website
Integrating rare genetic variants into DPYD pharmacogenetic testing may help preventing fluoropyrimidine-induced toxicity
The Pharmacogenomics Journal
by Romain Larrue, Sandy Fellah, Benjamin Hennart, Naoual Sabaouni, Nihad Boukrout, Cynthia Van der Hauwaert, Clément Delage, Meyling Cheok, Michaël Perrais, Christelle Cauffiez, Delphine Allorge, Nicolas Pottier
3M ago
The Pharmacogenomics Journal, Published online: 12 January 2024; doi:10.1038/s41397-023-00322-x Integrating rare genetic variants into DPYD pharmacogenetic testing may help preventing fluoropyrimidine-induced toxicity ..read more
Visit website
A software tool to adjust codeine dose based on CYP2D6 gene-pair polymorphisms and drug-drug interactions
The Pharmacogenomics Journal
by Yolande Saab, Zahi Nakad
5M ago
The Pharmacogenomics Journal, Published online: 09 November 2023; doi:10.1038/s41397-023-00318-7 A software tool to adjust codeine dose based on CYP2D6 gene-pair polymorphisms and drug-drug interactions ..read more
Visit website
Cytochrome P450-2D6 activity in people with codeine use disorder
The Pharmacogenomics Journal
by Mark R. C. Daglish, Sarah R. Reilly, Sam Mostafa, Cameron Edwards, Thomas M. O’Gorman, Jeremy S. Hayllar
5M ago
The Pharmacogenomics Journal, Published online: 09 November 2023; doi:10.1038/s41397-023-00319-6 Cytochrome P450-2D6 activity in people with codeine use disorder ..read more
Visit website

Follow The Pharmacogenomics Journal on FeedSpot

Continue with Google
Continue with Apple
OR